Lilly C Lee
Overview
Explore the profile of Lilly C Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Plumb I, Briggs Hagen M, Wiegand R, Dumyati G, Myers C, Harland K, et al.
Vaccine
. 2023 Nov;
42(10):2543-2552.
PMID: 37973512
Background: Bivalent mRNA vaccines were recommended since September 2022. However, coverage with a recent vaccine dose has been limited, and there are few robust estimates of bivalent VE against symptomatic...
2.
Plumb I, Mohr N, Hagen M, Wiegand R, Dumyati G, Harland K, et al.
Open Forum Infect Dis
. 2023 Oct;
10(10):ofad457.
PMID: 37799130
Background: Protection against symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019 [COVID-19]) can limit transmission and the risk of post-COVID conditions, and is particularly important among...
3.
Pilishvili T, Gierke R, Fleming-Dutra K, Farrar J, Mohr N, Talan D, et al.
N Engl J Med
. 2021 Sep;
385(25):e90.
PMID: 34551224
Background: The prioritization of U.S. health care personnel for early receipt of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease...
4.
Pilishvili T, Fleming-Dutra K, Farrar J, Gierke R, Mohr N, Talan D, et al.
MMWR Morb Mortal Wkly Rep
. 2021 May;
70(20):753-758.
PMID: 34014909
Throughout the COVID-19 pandemic, health care personnel (HCP) have been at high risk for exposure to SARS-CoV-2, the virus that causes COVID-19, through patient interactions and community exposure (1). The...